| Display title | Nicotinamide Mononucleotide (NMN) |
| Default sort key | Nicotinamide Mononucleotide (NMN) |
| Page length (in bytes) | 61,515 |
| Page ID | 2 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 2 |
| Counted as a content page | Yes |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
| Page image |  |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | Strimo (talk | contribs) |
| Date of page creation | 03:59, 8 September 2023 |
| Latest editor | Strimo (talk | contribs) |
| Date of latest edit | 23:05, 21 January 2024 |
| Total number of edits | 308 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Page title: (title)
This attribute controls the content of the <title> element. | NMN - Latest Research, Benefits, Dosage, Safety and more |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Explore comprehensive details on Nicotinamide Mononucleotide (NMN), its role in longevity, latest research findings, and health benefits. Dive into the science of NMN, understand its sources, legal status, and impact on healthy aging. |
Keywords: (keywords)
This attribute controls the content of the keywords and article:tag elements. | - NMN
- Nicotinamide Mononucleotide
- NAD+ Precursor
- anti-aging research
- longevity supplements
- healthy aging
- cellular health
- David A. Sinclair
- NMN sources
- NMN benefits
- NMN legal status
- NMN clinical trials
|
Article type: (type) | article |
